dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
Published 3 years ago • 134 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:28
dr. motzer on the tivo-3 trial examining tivozanib in advanced rcc
-
2:16
dr. robert motzer analyzes overall survival in the tivo-1 study
-
1:00
dr. vaishampayan on the potential of tivozanib in advanced rcc
-
6:19
asco gu 2013: tivo 1 study shows tivozanib an option for renal cell carcinoma: dr robert motzer
-
2:33
dr. robert motzer reviews the tivo-1 study survival findings
-
4:01
muc1 kidney disease: finding the roots of a molecular traffic jam
-
25:28
systemic treatment of metastatic renal cell cancer: what is state of the art in 2020? - l. albiges
-
12:54
oncotarget: onc201 kills breast cancer cells in vitro by targeting mitochondria
-
1:41
tivozanib tolerability shows potential advantage for patients with advanced rcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
0:52
dr. pal on the rationale for the tivo-3 trial with tivozanib in advanced rcc
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
2:32
dr. robert motzer discusses the safety and efficacy of tivozanib in kidney cancer
-
1:11
dr. motzer on the milestone of immunotherapy in rcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
1:15
dr. vaishampayan on the safety of tivozanib versus sorafenib in rcc
-
2:07
dr. subbiah on the importance of tivozanib in rcc
-
5:46
tivo-1, phase 3 study in advanced kidney cancer
-
4:18
tivozanib for refractory advanced rcc
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
1:20
tivozanib